Reduced Lp(a) with PCSK9 inhibitors in individuals with high Lp(a) at baseline contributes to CV risk reduction3' education - May 29, 2019 - Maastricht. The Netherlands - Prof. Chapman, PhD - Paris, France
This video was recorded at the EAS in Maastricht, the Netherlands, on May 29, 2019.
John Chapman is Research Professor at the Pierre and Marie Curie University, and Director Emeritus of the National Institute for Health and Medical Research (INSERM, unit 551) at the Pitié-Salpêtrière University Hospital in Paris, France.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.